Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era

The rapid emergence and global spread of COVID-19 have caused substantial global disruptions that have impacted malaria programs worldwide. Innovative strategies to enable countries aiming to eliminate malaria as well as those that are already certified as malaria-free, are needed to address malaria...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu, Guangyu (Author) , Cao, Yuanyuan (Author) , Zhang, Dongying (Author) , Zhang, Yuying (Author) , Xu, Yuhui (Author) , Lu, Yan (Author) , Chen, Qi (Author) , Zhu, Guoding (Author) , Yan, Jun (Author) , Müller, Olaf (Author) , Cao, Jun (Author)
Format: Article (Journal)
Language:English
Published: 21 June 2022
In: Globalization and health
Year: 2022, Volume: 18, Pages: 1-13
ISSN:1744-8603
DOI:10.1186/s12992-022-00858-w
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12992-022-00858-w
Get full text
Author Notes:Guangyu Lu, Yuanyuan Cao, Dongying Zhang, Yuying Zhang, Yuhui Xu, Yan Lu, Qi Chen, Guoding Zhu, Jun Yan, Olaf Müller and Jun Cao
Description
Summary:The rapid emergence and global spread of COVID-19 have caused substantial global disruptions that have impacted malaria programs worldwide. Innovative strategies to enable countries aiming to eliminate malaria as well as those that are already certified as malaria-free, are needed to address malaria importation in the context of the COVID-19 pandemic. China was certified as malaria-free in 2021 and now aims to prevent the malaria re-establishment. Nonpharmaceutical interventions such as entry screening, quarantining, and health education for individuals returning from international travel during the COVID-19 pandemic present both opportunities and challenges to the management of imported malaria. This study aimed to describe and analyze the operational challenges associated with an integrated surveillance and case management program in which malaria re-establishment prevention measures were incorporated into the COVID-19 program in China.
Item Description:Gesehen am 01.09.2022
Physical Description:Online Resource
ISSN:1744-8603
DOI:10.1186/s12992-022-00858-w